A K M Moyeenul Huq
Overview
Explore the profile of A K M Moyeenul Huq including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
12
Citations
32
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Roney M, Issahaku A, Huq A, Sapari S, Abdul Razak F, Wilhelm A, et al.
Cell Biochem Biophys
. 2024 Sep;
83(1):1321.
PMID: 39269561
No abstract available.
2.
Roney M, Huq A, Rullah K, Zamri N, Mohd Aluwi M
Cell Biochem Biophys
. 2024 Aug;
83(1):53-71.
PMID: 39112903
Diabetes mellitus (DM) is a long-term metabolic disease characterised by a controlled metabolism of fat, carbohydrates, and proteins. In recent decades, it has grown into a significant global public health...
3.
Roney M, Issahaku A, Huq A, Sapari S, Abdul Razak F, Wilhelm A, et al.
Cell Biochem Biophys
. 2024 Jul;
82(4):3351-3366.
PMID: 39020086
Diabetes mellitus (DM) a metabolic disorder characterized by high blood sugar levels causing damage to various organs over time. Current anti-diabetic drugs have limitations and side effects, prompting a search...
4.
Forid M, Patil R, Roney M, Huq A, Mohd Nasir M, Mohd Aluwi M, et al.
J Biomol Struct Dyn
. 2024 Mar;
:1-12.
PMID: 38520169
Interleukin-6 (IL-6) is a cytokine that involved in the different phases of wound healing. It is responsible for promoting inflammation, regulating tissue repair scar formation, stimulating the production of extracellular...
5.
Huq A, Roney M, Dubey A, Nasir M, Tufail A, Mohd Aluwi M, et al.
PLoS One
. 2024 Mar;
19(3):e0299238.
PMID: 38483871
Background: Currently, there is no antiviral medication for dengue, a potentially fatal tropical infectious illness spread by two mosquito species, Aedes aegypti and Aedes albopictus. The RdRp protease of dengue...
6.
Huq A, Roney M, Issahaku A, Sapari S, Abdul Razak F, Soliman M, et al.
J Biomol Struct Dyn
. 2023 Sep;
42(18):9325-9336.
PMID: 37676311
Dengue fever is now one of the major global health concerns particularly for tropical and sub-tropical countries. However, there has been no FDA approved medication to treat dengue fever. Researchers...
7.
Roney M, Issahaku A, Forid M, Huq A, Soliman M, Mohd Aluwi M, et al.
J Biomol Struct Dyn
. 2023 Mar;
41(24):14904-14913.
PMID: 36995164
Due to the rising increase in infectious diseases brought on by bacteria and anti-bacterial drug resistance, antibacterial therapy has become difficult. The majority of first-line antibiotics are no longer effective...
8.
Huq A, Roney M, Imran S, Khan S, Uddin M, Htar T, et al.
J Biomol Struct Dyn
. 2023 Feb;
41(23):13923-13936.
PMID: 36786766
Since the first prevalence of COVID-19 in 2019, it still remains the most devastating pandemic throughout the world. The current research aimed to find potential natural products to inhibit the...
9.
Roney M, Singh G, Huq A, Forid M, Wan Ishak W, Rullah K, et al.
Mol Biotechnol
. 2023 Feb;
66(4):696-706.
PMID: 36752937
The infection produced by the SARS-CoV-2 virus remains a significant health crisis worldwide. The lack of specific medications for COVID-19 necessitates a concerted effort to find the much-desired therapies for...
10.
Roney M, Huq A, Issahaku A, Soliman M, Hossain M, Mustafa A, et al.
J Biomol Struct Dyn
. 2023 Jan;
41(21):12186-12203.
PMID: 36645141
Dengue fever is a significant public health concern throughout the world, causing an estimated 500,000 hospitalizations and 20,000 deaths each year, despite the lack of effective therapies. The DENV-2 RdRp...